Methods We undertook a proof-of-concept open-label controlled study evaluating the safety and tolerability of the GLP-1 agonist Semaglutide administered as an add-on therapy to standard of care ...
Giuseppe Remuzzi and colleagues report that oral administration of acetyl-l-carnitine increases insulin sensitivity and glucose tolerance in individuals with a low glucose disposal rate (GDR).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback